- Home
- GENK vs SINT Comparison
GENK vs SINT Comparison
Compare GENK & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENK | SINT |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | 2700 | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 11.1M |
| IPO Year | 2023 | 2007 |
Fundamental Metrics
Financial Performance| Metric | GENK | SINT |
|---|---|---|
| Price | $2.09 | $1.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $4.50 | ★ $11.00 |
| AVG Volume (30 Days) | 18.5K | ★ 42.8K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.88% | N/A |
| EPS Growth | ★ 62.50 | 59.45 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $208,380,000.00 | $1,018,000.00 |
| Revenue This Year | $4.79 | $30.26 |
| Revenue Next Year | $7.48 | $413.20 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.12 | N/A |
| 52 Week Low | $1.43 | $1.86 |
| 52 Week High | $4.98 | $6.78 |
Technical Indicators
Market Signals| Indicator | GENK | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 50.18 | 40.55 |
| Support Level | $1.53 | $1.93 |
| Resistance Level | $2.36 | $2.55 |
| Average True Range (ATR) | 0.17 | 0.18 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 56.13 | 31.82 |
Price Performance
Historical ComparisonAbout GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. The group operates its restaurants in California, Arizona, Hawaii, Nevada, Texas, New York, Oregon, North Carolina, Washington, New Jersey, Florida and South Korea.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.